LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析

◆英語タイトル:LifeAssays AB (LIFE B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011136
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary systems, among others. LifeAssays’ human system offers solutions for measuring biological markers. The company’s VetReader System provides an alternative for POC testing utilizing the unique and patented magnetic immunoassay (MIA) technique. It offers its point-of-care diagnostic testing equipment for community, health centres, primary physicians and veterinarians. The company markets products through a network of distributors across Europe. LifeAssays is headquartered in Lund, Sweden.

LifeAssays AB (LIFE B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LifeAssays AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeAssays AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeAssays AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeAssays AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeAssays AB, Medical Equipment, Deal Details 10
Partnerships 10
LifeAssays Enters into Agreement with Dynamics Biotech 10
Equity Offering 11
LifeAssays Raises USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 11
LifeAssays Raises USD2 Million in Rights offering of Units 12
LifeAssays Raises USD2 Million in Rights Offering of Shares 13
LifeAssays Raises USD3.2 Million in Issue of Preferential Rights 14
LifeAssays Completes Rights Issue Of US$2.5 Million 15
LifeAssays Completes Rights Issue Of Common Stock For US$1.5 Million 16
Acquisition 17
LifeAssays Acquires Magnasense Technologies for USD0.5 Million 17
LifeAssays AB – Key Competitors 18
LifeAssays AB – Key Employees 19
LifeAssays AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
LifeAssays AB, Medical Equipment, Key Facts, 2016 2
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LifeAssays AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeAssays AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeAssays AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeAssays AB, Deals By Market, 2011 to YTD 2017 8
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeAssays Enters into Agreement with Dynamics Biotech 10
LifeAssays Raises USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 11
LifeAssays Raises USD2 Million in Rights offering of Units 12
LifeAssays Raises USD2 Million in Rights Offering of Shares 13
LifeAssays Raises USD3.2 Million in Issue of Preferential Rights 14
LifeAssays Completes Rights Issue Of US$2.5 Million 15
LifeAssays Completes Rights Issue Of Common Stock For US$1.5 Million 16
LifeAssays Acquires Magnasense Technologies for USD0.5 Million 17
LifeAssays AB, Key Competitors 18
LifeAssays AB, Key Employees 19
LifeAssays AB, Subsidiaries 20

★海外企業調査レポート[LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Epizyme Inc (EPZM):製薬・医療:M&Aディール及び事業提携情報
    Summary Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. The company discovers and develops small molecule inhibitors of a class of enzymes, namely, histone methyl transferases (HMTs) and other chromatin …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • InvitroCue Ltd (IVQ)-製薬・医療分野:企業M&A・提携分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd is a provider of bio-analytic solutions. The company offers digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image arch …
  • IMPSA SA:企業の戦略的SWOT分析
    IMPSA SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that pro …
  • Extreme Networks Inc (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks Inc (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務情報
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • EOS imaging SA (EOSI):医療機器:M&Aディール及び事業提携情報
    Summary EOS imaging SA (EOS Imaging) is an orthopedic imaging company that designs, develops, and markets EOS patented medical imaging system. EOS captures whole body images of a standing patient in a single scan without any stitching or vertical distortion. Through EOS, the company provides the ful …
  • Royal FrieslandCampina N.V.:企業のM&A・事業提携・投資動向
    Royal FrieslandCampina N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal FrieslandCampina N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Aster DM Healthcare (ASTERDM):製薬・医療:M&Aディール及び事業提携情報
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as mobile medical units, cardiac surgery, early cancer detection centers, village adoption, and dialys …
  • Orbotech Ltd.:企業の戦略的SWOT分析
    Orbotech Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BE Semiconductor Industries NV (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries NV (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Polenergia SA (PEP):電力:M&Aディール及び事業提携情報
    Summary Polenergia SA (Polenergia) formerly Polish Energy Partners SA develops, implements and operates projects related to production of electricity and fuels. It offers services such as project implementation and supervision of construction, management of power facilities, production and sales of …
  • Liberty Holdings Ltd:戦略・SWOT・企業財務分析
    Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Koninklijke Ahold Delhaize NV (AD):企業の財務・戦略的SWOT分析
    Koninklijke Ahold Delhaize NV (AD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • inVentiv Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary inVentiv Health Inc (inVentiv) is a Clinical Research Organization (CRO) and Contract Commercial Organization (CCO). The company offers a broad range of clinical development and commercialization services develop and marketing their products and services. Few of its service offerings include …
  • Pan Orient Energy Corp. (POE):石油・ガス:M&Aディール及び事業提携情報
    Summary Pan Orient Energy Corp (POE) is an independent upstream oil and gas company. The company has interests in onshore oil and gas assets in Thailand and Indonesia. It also has interests in Andora Energy Corporation, which holds properties in Northern Alberta. Its assets in Thailand include Conce …
  • Ali Baba:企業の戦略・SWOT・財務情報
    Ali Baba - Strategy, SWOT and Corporate Finance Report Summary Ali Baba - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Groupe PSA:企業の戦略・SWOT・財務情報
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆